Xisto Mariana I D S, Caramalho Rita D F, Rocha Débora A S, Ferreira-Pereira Antonio, Sartori Bettina, Barreto-Bergter Eliana, Junqueira Maria L, Lass-Flörl Cornelia, Lackner Michaela
Division of Hygiene and Medical Microbiology, Innsbruck Medical University, Innsbruck, Austria.
Laboratório de Química Biológica de Microorganismos, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
J Antimicrob Chemother. 2017 Apr 1;72(4):988-992. doi: 10.1093/jac/dkw558.
Candidaemia is a public health problem mainly in hospitalized individuals worldwide. In Brazil, Candida albicans is the most prevalent species that causes candidaemia, followed by Candida tropicalis and Candida parapsilosis . Few data on the abundance of antifungal resistance are available for Latin America.
We analysed the frequency of azole and echinocandin resistance in Candida isolates ( n = 75) collected between 2012 and 2014 at the University Hospital of Federal University of Juiz de Fora (Brazil). The primary targets erg11 (azoles) and fks1 (echinocandins) were sequenced and modelled at the protein level. Antifungal susceptibility testing was performed according to CLSI (M27-A3 and M27-S4) and according to EUCAST.
The three most frequent species were C. albicans (38.0%), C. tropicalis (30.0%) and Candida glabrata (17.0%). Azole resistance was observed in 27.0% of all Candida isolates, while 20.0% of all isolates were echinocandin resistant. A novel mutation in erg11 at location K143R was found to be associated with phenotypically pan-azole-resistant C. tropicalis isolates. This mutation maps near the active binding site of erg11 and is likely to confer pan-azole resistance to C. tropicalis .
A novel point mutation (K143R) located in the erg11 gene of C. tropicalis was found in pan-azole-resistant strains. According to our protein homology model, it is very likely that the mutation K143R causes pan-azole resistance in C. tropicalis . Moreover, an up-regulation of ABC transporters was observed, which can add up to a pan-azole-resistant phenotype.
念珠菌血症是一个主要在全球住院患者中出现的公共卫生问题。在巴西,白色念珠菌是引起念珠菌血症最常见的菌种,其次是热带念珠菌和近平滑念珠菌。拉丁美洲关于抗真菌耐药性发生率的数据很少。
我们分析了2012年至2014年期间在巴西茹伊斯迪福拉联邦大学大学医院收集的念珠菌分离株(n = 75)中唑类和棘白菌素耐药性的频率。对主要靶点erg11(唑类)和fks1(棘白菌素)进行测序并在蛋白质水平上建模。根据CLSI(M27 - A3和M27 - S4)以及EUCAST进行抗真菌药敏试验。
三种最常见的菌种是白色念珠菌(38.0%)、热带念珠菌(30.0%)和光滑念珠菌(17.0%)。在所有念珠菌分离株中,27.0%观察到唑类耐药,而所有分离株中有20.0%对棘白菌素耐药。发现在erg11基因位置K143R处有一个新突变与表型上对唑类全耐药的热带念珠菌分离株相关。该突变位于erg11的活性结合位点附近,可能赋予热带念珠菌对唑类的全耐药性。
在对唑类全耐药的菌株中发现热带念珠菌erg11基因存在一个新的点突变(K143R)。根据我们的蛋白质同源性模型,K143R突变很可能导致热带念珠菌对唑类产生全耐药性。此外,观察到ABC转运蛋白上调,这可能导致对唑类的全耐药表型。